关键词：医药；糖尿病；遗传标记；肥胖
摘 要：The increasing incidence of obesity and Type 2 Diabetes (T2D) confers significant burden on the US civilian and military healthcare system. It is hypothesized that the risk of future obesity and T2D can be mitigated by targeted interventions during early adulthood which are based on individual biological variability (e.g., personalized medicine using genetic biomarkers).